Matches in Wikidata for { <http://www.wikidata.org/entity/Q33437691> ?p ?o ?g. }
- Q33437691 description "2016 nî lūn-bûn" @default.
- Q33437691 description "2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q33437691 description "2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված" @default.
- Q33437691 description "2016年の論文" @default.
- Q33437691 description "2016年論文" @default.
- Q33437691 description "2016年論文" @default.
- Q33437691 description "2016年論文" @default.
- Q33437691 description "2016年論文" @default.
- Q33437691 description "2016年論文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016年论文" @default.
- Q33437691 description "2016년 논문" @default.
- Q33437691 description "article científic" @default.
- Q33437691 description "article scientific" @default.
- Q33437691 description "article scientifique (publié 2016)" @default.
- Q33437691 description "articol științific" @default.
- Q33437691 description "articolo scientifico" @default.
- Q33437691 description "artigo científico (publicado na 2016)" @default.
- Q33437691 description "artigo científico (publicado na 2016)" @default.
- Q33437691 description "artigo científico" @default.
- Q33437691 description "artikull shkencor" @default.
- Q33437691 description "artikulong pang-agham" @default.
- Q33437691 description "artykuł naukowy" @default.
- Q33437691 description "artículo científico publicado en 2016" @default.
- Q33437691 description "artículu científicu espublizáu en 2016" @default.
- Q33437691 description "bilimsel makale" @default.
- Q33437691 description "bài báo khoa học" @default.
- Q33437691 description "mokslinis straipsnis" @default.
- Q33437691 description "naučni članak" @default.
- Q33437691 description "scienca artikolo" @default.
- Q33437691 description "scientific article" @default.
- Q33437691 description "teaduslik artikkel" @default.
- Q33437691 description "tieteellinen artikkeli" @default.
- Q33437691 description "tudományos cikk" @default.
- Q33437691 description "vedecký článok" @default.
- Q33437691 description "vetenskaplig artikel" @default.
- Q33437691 description "videnskabelig artikel (udgivet 2016)" @default.
- Q33437691 description "vitenskapelig artikkel" @default.
- Q33437691 description "vitskapeleg artikkel" @default.
- Q33437691 description "vědecký článek" @default.
- Q33437691 description "wetenschappelijk artikel" @default.
- Q33437691 description "wissenschaftlicher Artikel" @default.
- Q33437691 description "επιστημονικό άρθρο" @default.
- Q33437691 description "мақолаи илмӣ" @default.
- Q33437691 description "мақолаи илмӣ" @default.
- Q33437691 description "наукова стаття, опублікована в грудні 2016" @default.
- Q33437691 description "научна статия" @default.
- Q33437691 description "научная статья" @default.
- Q33437691 description "научни чланак" @default.
- Q33437691 description "научни чланак" @default.
- Q33437691 description "מאמר מדעי" @default.
- Q33437691 description "سائنسی مضمون" @default.
- Q33437691 description "مقالة علمية" @default.
- Q33437691 description "مقالهٔ علمی" @default.
- Q33437691 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33437691 description "บทความทางวิทยาศาสตร์" @default.
- Q33437691 description "სამეცნიერო სტატია" @default.
- Q33437691 name "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 name "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 name "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 type Item @default.
- Q33437691 label "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 label "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 label "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 prefLabel "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 prefLabel "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 prefLabel "Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial." @default.
- Q33437691 P1433 Q33437691-1418606D-6877-459E-A387-84AF8D8C2CEE @default.
- Q33437691 P1476 Q33437691-70D46C32-0DF0-48FD-979E-BACD39F27AEA @default.
- Q33437691 P2093 Q33437691-11E97CF6-B0E4-4188-88F9-B9DC452E9C74 @default.
- Q33437691 P2093 Q33437691-1C52ACCB-42B0-438D-9EB1-2BF07967BC89 @default.
- Q33437691 P2093 Q33437691-35DC6805-56BC-424C-9F29-63575034E2A1 @default.
- Q33437691 P2093 Q33437691-53168476-352F-4408-A3ED-E67DB6E7646F @default.
- Q33437691 P2093 Q33437691-5AD8EDFC-6348-4643-B1DE-5EF567A24D04 @default.
- Q33437691 P2093 Q33437691-61196CFD-E542-47B1-800B-87C0DD26C0BC @default.
- Q33437691 P2093 Q33437691-64879FF6-29C7-4CE6-AFC6-BCCB4E54653C @default.
- Q33437691 P2093 Q33437691-7D602F0A-0897-4A7B-BE64-BD77E9C64056 @default.
- Q33437691 P2093 Q33437691-8005AA02-0C48-41B3-A25A-CCA27C4679A2 @default.
- Q33437691 P2093 Q33437691-99BC6220-6080-439D-81B0-3E4A68BDF372 @default.
- Q33437691 P2093 Q33437691-9AFD1D4C-BBD5-4B80-B329-9A16C68DDFB8 @default.
- Q33437691 P2093 Q33437691-A4540D55-9796-4E55-917A-2AA22BBE06E8 @default.
- Q33437691 P2093 Q33437691-A6FE0100-88BB-4DB8-809C-A67137F6B0E5 @default.
- Q33437691 P2093 Q33437691-A9702116-B175-45A8-86CB-13AAE921BCBD @default.
- Q33437691 P2093 Q33437691-B7E9B9F9-1D08-40A1-81C1-2EAB52ACEAAC @default.
- Q33437691 P2093 Q33437691-BDD5A8D2-15EB-479D-8011-65475C89F9A8 @default.
- Q33437691 P2093 Q33437691-D4B66066-182B-4220-8A40-2CFCD27D9695 @default.
- Q33437691 P2093 Q33437691-D55244D4-19DF-4FA9-91EF-A805C667A0F8 @default.
- Q33437691 P2093 Q33437691-DA64C2B0-6A43-4F6F-B50D-04561EAB68E9 @default.
- Q33437691 P2093 Q33437691-DE0ECC08-A139-47A7-841F-38920C0CF30B @default.
- Q33437691 P2093 Q33437691-DF4F0757-80AC-46B6-91A5-F91E28B45D22 @default.
- Q33437691 P2093 Q33437691-E81C52FF-EEBC-4650-A597-69906E63EA8F @default.
- Q33437691 P2860 Q33437691-02C222C0-F66D-47AC-8B84-057CC151E587 @default.
- Q33437691 P2860 Q33437691-0662A68F-DA76-4F0A-B02C-44BEEEA9787C @default.
- Q33437691 P2860 Q33437691-099C23E7-4102-40EB-A40F-767D4441CD5E @default.
- Q33437691 P2860 Q33437691-10889BD9-F6E8-468A-9B89-8B9F006387B4 @default.
- Q33437691 P2860 Q33437691-1938F504-A138-47A2-9D6A-4C3B51AA5476 @default.